The Elon Musk-founded Neuralink, the medical device company developing implantable brain-computer interface microchips, has received U.S. Food and Drug Administration approval to start human clinical trials as early as this summer. The company announced what it calls “an important first step” and expects to share more information on recruitment for the clinical trial in the near future. “We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!” the company tweeted. “This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people. Recruitment is not yet open for our clinical trial. We’ll announce more information on this soon!”

While details are still scant, the trial is expected to focus on Neuralink’s brain-computer interface (BCI), a Class III medical device that connects the brain to an external computer using a Bluetooth signal. With this connection, the device — a coin-sized chip called the “Link” — allows for continuous communication and is designed to not only “read” neural activity but “write” signals into the brain. Musk has said Neuralink could potentially restore eyesight and motor function for disabled patients and offer the ability to control electronic devices mentally. Neuralink does not currently have any clinical trials available for enrollment but has created a patient registry for those interested in participating in future trials.

Musk has said his inspiration behind the company in the first place was to be a “risk mitigation for digital super-intelligence.” “The reason I created Neuralink long-term as a risk mitigation for digital super-intelligence, in that if we are able to effectively achieve symbiosis with digital intelligence, then … the collective human will is better able to steer things in the direction that we’d like, or even with benign AI, at least go along for the ride,” he said in a 2021 interview. Among other goals, Musk said he’s confident Neuralink will ultimately allow paraplegic or even tetraplegic to operate a phone “faster than someone who has … working hands.”

Dr. Travis Losey, the vice-chair of the department of neurology and co-director of the Comprehensive Epilepsy Center at Loma Linda University in southern California, said in a 2021 interview that when it comes to the use of brain interface technology, the purpose should be to heal something that was harmed by disease or a disorder. “The core ethical issue with the brain-computer interface is similar to issues with medication,” he offered. “I think it’s only ethical to use medications when they are being used to restore function that has been lost or affected by a disease. The same principles would apply to brain-computer interfaces.”

Biblical Connections: While the technology that Mr. Musk and others are creating could be a great benefit in the medical field, it could also be possible that this type of technology or something close to it could be used in the future to create the Mark of the Beast, written about in Revelation 13. If one combines the idea of a completely digital currency with the combination of neurochips like this technology, then one could easily see how a Mark of the Beast could be pushed through in the times of the Antichrist that cannot be faked, that could be taken everywhere and that would allow for access to the global markets. While we should not reject technology meaninglessly, we also should recognize that the advancements could be getting us closer to the Rapture and the Tribulation.

PRAY: Pray that these types of technological advancements will be used worldwide for good and to truly help people.